JP Morgan Chase
INSY

JP Morgan Chase’s Insys Therapeutics, Inc. INSY Stock Holding History

JP Morgan Chase’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-110,000
Closed -$3.13M – 4872
2015
Q3 		$3.13M Buy
+110,000
New +$4.05M ﹤0.01% 2519

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

JP Morgan Chase's INSY Position: Q2 2019 in Review

JP Morgan Chase sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 8,978 shares — an estimated $41K sold.

JP Morgan Chase first reported a position in INSY in Q2 2013 and held it in 20 quarters. The position peaked at $8.65M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • JP Morgan Chase reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • JP Morgan Chase sold 8,978 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $41K.
  • JP Morgan Chase first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 20 quarters.
  • JP Morgan Chase's Insys Therapeutics, Inc. position peaked at $8.65M in Q3 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.